CN102925579B - Idh2基因突变的快速检测方法 - Google Patents
Idh2基因突变的快速检测方法 Download PDFInfo
- Publication number
- CN102925579B CN102925579B CN201210461630.XA CN201210461630A CN102925579B CN 102925579 B CN102925579 B CN 102925579B CN 201210461630 A CN201210461630 A CN 201210461630A CN 102925579 B CN102925579 B CN 102925579B
- Authority
- CN
- China
- Prior art keywords
- wild
- primers
- primer
- object fragment
- sudden change
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 17
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 4
- 101150104906 Idh2 gene Proteins 0.000 title abstract description 5
- 239000012634 fragment Substances 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000002844 melting Methods 0.000 claims abstract description 18
- 230000008018 melting Effects 0.000 claims abstract description 18
- 230000000869 mutational effect Effects 0.000 claims abstract description 15
- 230000008859 change Effects 0.000 claims description 46
- 239000013641 positive control Substances 0.000 claims description 18
- 230000004304 visual acuity Effects 0.000 claims description 15
- 238000010790 dilution Methods 0.000 claims description 14
- 239000012895 dilution Substances 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 238000000137 annealing Methods 0.000 claims description 6
- 238000013461 design Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000003745 diagnosis Methods 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 claims description 5
- 239000013642 negative control Substances 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000003146 anticoagulant agent Substances 0.000 claims description 3
- 229940127219 anticoagulant drug Drugs 0.000 claims description 3
- 230000010100 anticoagulation Effects 0.000 claims description 3
- 238000003149 assay kit Methods 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 claims description 3
- 239000003471 mutagenic agent Substances 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 3
- 239000011886 peripheral blood Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 238000007400 DNA extraction Methods 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 238000004458 analytical method Methods 0.000 claims 1
- 102100037845 Isocitrate dehydrogenase [NADP], mitochondrial Human genes 0.000 abstract description 28
- 238000003752 polymerase chain reaction Methods 0.000 abstract description 27
- 101000599886 Homo sapiens Isocitrate dehydrogenase [NADP], mitochondrial Proteins 0.000 abstract description 20
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000004907 flux Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 abstract description 2
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 abstract description 2
- 230000003321 amplification Effects 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- 101710177984 Isocitrate dehydrogenase [NADP] Proteins 0.000 description 8
- 101710102690 Isocitrate dehydrogenase [NADP] cytoplasmic Proteins 0.000 description 8
- 101710175291 Isocitrate dehydrogenase [NADP], mitochondrial Proteins 0.000 description 8
- 101710157228 Isoepoxydon dehydrogenase patN Proteins 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 238000011880 melting curve analysis Methods 0.000 description 6
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 4
- 101001042041 Bos taurus Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 description 4
- 101000960234 Homo sapiens Isocitrate dehydrogenase [NADP] cytoplasmic Proteins 0.000 description 4
- 102100039905 Isocitrate dehydrogenase [NADP] cytoplasmic Human genes 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
- 208000014767 Myeloproliferative disease Diseases 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 2
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 2
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101001014196 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 101150020771 IDH gene Proteins 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
- 108700015928 Mitogen-activated protein kinase 13 Proteins 0.000 description 1
- 101000615913 Oryza sativa subsp. japonica Mitogen-activated protein kinase kinase 1 Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000004079 Prolyl Hydroxylases Human genes 0.000 description 1
- 108010043005 Prolyl Hydroxylases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000035567 cellular accumulation Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
MasterMix组成: | (1x) | (5x) |
25mM MgCl2 | 1.2μl | 6μl |
2μM IDH2F primer | 1μl | 5μl |
2μM IDH2R primer | 1μl | 5μl |
H2O | 1.3μl | 6.5μl |
Σ= | 4.5μl | 22.5μl |
引物 | 引物序列(5’-3’) |
IDH2F | AAAACATCCCACGCCTAGTCC |
IDH2R | ACTGCAGAGACAAGAGGATGG |
IDH2M | tc accattggcGGGcacgccca t |
IDH2MR | atgggcgtgCCCgccaatggtga |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210461630.XA CN102925579B (zh) | 2012-11-16 | 2012-11-16 | Idh2基因突变的快速检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210461630.XA CN102925579B (zh) | 2012-11-16 | 2012-11-16 | Idh2基因突变的快速检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102925579A CN102925579A (zh) | 2013-02-13 |
CN102925579B true CN102925579B (zh) | 2014-12-17 |
Family
ID=47640502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210461630.XA Expired - Fee Related CN102925579B (zh) | 2012-11-16 | 2012-11-16 | Idh2基因突变的快速检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102925579B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104073548A (zh) * | 2013-03-27 | 2014-10-01 | 沈迪 | 基于溶解曲线的单核苷酸多态性检测方法及其试剂盒 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101265503A (zh) * | 2003-03-10 | 2008-09-17 | 独立行政法人科学技术振兴机构 | 检测间充质干细胞的标记和采用该标记识别间充质干细胞的方法 |
EP2253716A1 (en) * | 2009-05-15 | 2010-11-24 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Diagnostic methods for the prognosis of a brain tumor |
CN102732633A (zh) * | 2012-07-06 | 2012-10-17 | 广州好芝生物科技有限公司 | 人idh基因突变的检测引物和试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100821457B1 (ko) * | 2006-11-24 | 2008-04-11 | (주)아모레퍼시픽 | Idh3a 프로모터 및 루시퍼라제 함유 벡터로형질전환된 세포주, 및 그를 이용한 비만억제 후보물질검색방법 |
-
2012
- 2012-11-16 CN CN201210461630.XA patent/CN102925579B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101265503A (zh) * | 2003-03-10 | 2008-09-17 | 独立行政法人科学技术振兴机构 | 检测间充质干细胞的标记和采用该标记识别间充质干细胞的方法 |
EP2253716A1 (en) * | 2009-05-15 | 2010-11-24 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Diagnostic methods for the prognosis of a brain tumor |
CN102732633A (zh) * | 2012-07-06 | 2012-10-17 | 广州好芝生物科技有限公司 | 人idh基因突变的检测引物和试剂盒 |
Non-Patent Citations (1)
Title |
---|
高分辨率熔解曲线及其在分子诊断中的应用;沈薇等;《检验医学》;20111031;第26卷(第10期);706-709 * |
Also Published As
Publication number | Publication date |
---|---|
CN102925579A (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | An ultrasensitive label-free electrochemical biosensor for microRNA-21 detection based on a 2′-O-methyl modified DNAzyme and duplex-specific nuclease assisted target recycling | |
CN105821138B (zh) | 一种基于连接反应构建双茎环结构dna模板检测核酸的方法 | |
CN106497920A (zh) | 一种用于非小细胞肺癌基因突变检测的文库构建方法及试剂盒 | |
CN110964814B (zh) | 用于核酸序列变异检测的引物、组合物及方法 | |
Najafzadeh et al. | Rapid identification of fungal pathogens by rolling circle amplification using Fonsecaea as a model | |
CN103525901B (zh) | Mek1基因突变的快速检测方法 | |
CN104818318A (zh) | 一次性检测肺癌多重基因的引物、探针、检测体系和试剂盒 | |
Wang et al. | Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection | |
CN114381550B (zh) | 用于hpv分型的多靶标核酸检测试剂盒和检测方法 | |
Wu et al. | Target-independent hybridization chain reaction-fluorescence resonance energy transfer for sensitive assay of ctDNA based on Cas12a | |
Wang et al. | Universal and highly accurate detection of circulating tumor DNA mutation in non-small cell lung cancer based on CRISPR/Cas12a system | |
Qiu et al. | A CRISPR‐based nucleic acid detection platform (CRISPR‐CPA): Application for detection of Nocardia farcinica | |
CN102925580B (zh) | Notch1基因突变的快速检测方法 | |
CN109971832A (zh) | 一种检测基因突变的试剂盒、方法及其用途 | |
CN102925579B (zh) | Idh2基因突变的快速检测方法 | |
CN103397080A (zh) | Pten基因突变的快速检测方法 | |
CN107641649B (zh) | 检测微卫星nr27位点稳定性的引物对、试剂盒及方法 | |
CN111719015A (zh) | 一种人类免疫缺陷病毒hiv-1的检测试剂盒 | |
WO2020167597A1 (en) | Solution-phase, trans-activated reporter systems for use in crispr-based nucleic acid sequence detections | |
CN102925582B (zh) | β-Catenin基因突变的快速检测方法 | |
Friedman et al. | Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients | |
CN103667428B (zh) | Caveolin-1基因突变的快速检测方法 | |
KR102604416B1 (ko) | 가이드 rna를 이용한 유전자 분석 방법 | |
CN110616261A (zh) | 一种用于检测egfr基因t790m突变的试剂盒及检测方法 | |
CN103436593A (zh) | p53基因突变的快速检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI SAIAN MEDICAL TEST INSTITUTE CO., LTD. Free format text: FORMER OWNER: SHANGHAI SAIAN BIOLOGICAL MEDICAL TECHNOLOGY CO., LTD. Effective date: 20141105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200032 BAOSHAN, SHANGHAI TO: 201900 BAOSHAN, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141105 Address after: 201900, Shanghai, Baoshan District, Shanghai Road, No. 1888, first floor Applicant after: SHANGHAI SHINE MEDICAL INSTITUTE Co.,Ltd. Address before: 200032 209D room, No. 668, Da Dao, Baoshan District, Shanghai Applicant before: SHANGHAI SHINES PHARMACEUTICAL CO.,LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200407 Granted publication date: 20141217 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230407 Granted publication date: 20141217 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141217 |